Review ArticleInternational Journal of Basic & Clinical Pharmacology
Publication: Anti-nicotine vaccine: current status
Int J Basic Clin Pharmacol. 2015;4(6):1309-1313.DOI10.18203/2319-2003.ijbcp20151380
Abstract
Tobacco abuse has an enormous impact on health. Nicotine is the main substance responsible for dependence on tobacco-containing products. The vast majority of cigarette smokers who try to quit ultimately fail because of high relapse rates. Clearly, novel approaches are needed for the treatment and prevention of nicotine addiction. Having an efficient vaccine that would generate antibodies to sequester the drug and prevent its access to the brain could go a long way toward helping a motivated addict quit an addiction.
Keywords
Affiliations
- Department of Pharmacology, Teerthanker Mahaveer Medical College and Research Centre, Moradabad, Uttar Pradesh, India
- Department of Oral Medicine and Radiology, Teerthanker Mahaveer Dental College and Research Centre, Moradabad, Uttar Pradesh, India
- Department of Pulmonary Medicine, Darbhanga Medical College and Hospital, Darbhanga, Bihar, India
